PALB2 mutation as a predictive biomarker for immunotherapy in patients with advanced melanoma: Results from (a pooled analysis of) five multicenter, randomized clinical trials. The PPV thresholds can ...
Preferences for research participation among individuals with Lynch syndrome: Findings from the HEROIC Registry. Real-world evidence of treatment patterns and pharmacy costs among patients with ...
Expertise from Forbes Councils members, operated under license. Opinions expressed are those of the author. Intelligent organizations prioritize investments in machine learning and real-time data to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback